Literature DB >> 14550878

Immune deficiency and autoimmunity.

Amos Etzioni1.   

Abstract

Immunodeficiency and autoimmune phenomena may occur concomitantly in the same individual. Many immune deficiency syndromes, mainly humoral defects, are associated with autoimmune disorders. Hematological manifestations, such as thrombocytopenia and hemolytic anemia, are the most common presentation, but many other autoimmune mediated conditions have also been described. Persistent antigen stimulation, due to an inherently defective immune system ability to eradicate pathogenesis is the primary cause leading to autoimmunity in patients with primary immunodeficiency states. Other factors leading to the increase incidence of autoimmune manifestion will be discussed in the present review. Treatment with intravenous gammagluobuilin may ameliorate the autoimmune disorder and bone marrow transplantation can cure both conditions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14550878     DOI: 10.1016/s1568-9972(03)00052-1

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  28 in total

1.  Immunodeficiency and autoimmune enterocolopathy linked to NFAT5 haploinsufficiency.

Authors:  Brigid S Boland; Christella E Widjaja; Asoka Banno; Bing Zhang; Stephanie H Kim; Samantha Stoven; Michael R Peterson; Marilyn C Jones; H Irene Su; Sheila E Crowe; Jack D Bui; Samuel B Ho; Yoshinaga Okugawa; Ajay Goel; Eric V Marietta; Mahdieh Khosroheidari; Kristen Jepsen; Jose Aramburu; Cristina López-Rodríguez; William J Sandborn; Joseph A Murray; Olivier Harismendy; John T Chang
Journal:  J Immunol       Date:  2015-02-09       Impact factor: 5.422

Review 2.  Balancing autoaggressive and protective T cell responses.

Authors:  Abul K Abbas; Jens Lohr; Birgit Knoechel
Journal:  J Autoimmun       Date:  2007-03-23       Impact factor: 7.094

Review 3.  Common variable immune deficiency: reviews, continued puzzles, and a new registry.

Authors:  Charlotte Cunningham-Rundles; Adina Kay Knight
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

4.  Overall reduction in antibody production could contribute to generate pathogenic autoantibodies and autoimmune manifestations.

Authors:  Ricardo García-Muñoz
Journal:  Clin Rheumatol       Date:  2008-12-18       Impact factor: 2.980

5.  Profile of autoantibodies against phosphorylcholine and cross-reactivity to oxidation-specific neoantigens in selective IgA deficiency with or without autoimmune diseases.

Authors:  Ana Elisa Fusaro; Kristine Fahl; Elaine Cristina Cardoso; Cyro Alves de Brito; Cristina M A Jacob; Magda Carneiro-Sampaio; Alberto J S Duarte; Maria Notomi Sato
Journal:  J Clin Immunol       Date:  2010-08-25       Impact factor: 8.317

Review 6.  Clinical manifestations of disease in X-linked carriers of chronic granulomatous disease.

Authors:  A C Battersby; A M Cale; D Goldblatt; A R Gennery
Journal:  J Clin Immunol       Date:  2013-11       Impact factor: 8.317

Review 7.  Autoimmunity in IgA deficiency: revisiting the role of IgA as a silent housekeeper.

Authors:  Cristina M A Jacob; Antonio C Pastorino; Kristine Fahl; Magda Carneiro-Sampaio; Renato C Monteiro
Journal:  J Clin Immunol       Date:  2008-01-17       Impact factor: 8.317

Review 8.  Complement and autoimmunity.

Authors:  Eleonora Ballanti; Carlo Perricone; Elisabetta Greco; Marta Ballanti; Gioia Di Muzio; Maria Sole Chimenti; Roberto Perricone
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

9.  Chronic granulomatous disease as a risk factor for autoimmune disease.

Authors:  Suk See De Ravin; Nora Naumann; Edward W Cowen; Julia Friend; Dianne Hilligoss; Martha Marquesen; James E Balow; Karyl S Barron; Maria L Turner; John I Gallin; Harry L Malech
Journal:  J Allergy Clin Immunol       Date:  2008-09-26       Impact factor: 10.793

Review 10.  Autoimmunity in immunodeficiency.

Authors:  Krista Todoric; Jessica B Koontz; Daniel Mattox; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.